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Abstract: The cationic ruthenium-hydride complex, formed in-situ from the treatment 
of the tetranuclear ruthenium-hydride complex {[(PCy3)(CO)RuH]4(μ4-O)(μ3-OH)(μ2-
OH)} with HBF4·OEt2, was found to be a highly effective catalyst for the intermolecular 
coupling reaction of arylketones and 1-alkenes to give the substituted indene and 
ortho-C–H insertion products. The formation of the indene products was resulted from 
the initial alkene isomerization followed by regioselective ortho-C–H insertion of 2-
alkene and the dehydrative cyclization. The preliminary mechanistic studies revealed a 
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rapid and reversible ortho-C–H bond activation followed by the rate-limiting C–C bond 
formation step for the coupling reaction. 
Electrophilic late transition metal complexes have been found to 
be highly effective in mediating unreactive C–H and C–C bond 
activation reactions, the activity and selectivity patterns of which are 
often complementary to their neutral counterparts.1 In a series of 
seminal reports, electrophilic Pt, Hg and Pd catalysts have been 
successfully developed and utilized for Shilov's C–H oxidation and 
functionalization reactions of alkanes and other hydrocarbons.2 
Extensive research on electrophilic Pd and Pt complexes have also led 
to a detailed mechanistic understanding on the alkane oxidation 
reaction,3 as well as to the applications in the synthesis of complex 
organic molecules.4 Most notably, electrophilic Pd and Pt catalysts have 
been found to be effective for a number synthetically useful coupling 
reactions involving C–H bond activation.5 Remarkable activity of 
cationic Ru and Ir complexes toward C–C bond activation reactions 
have also been demonstrated under stoichiometric conditions.6 
Our own interest in electrophilic late metal catalysts stemmed 
from the recent discoveries that cationic ruthenium-hydride catalysts 
are highly effective in promoting both hydrogenation reactions,7 as 
well as for selective coupling reactions involving C–H and N–H bond 
activation.8 We have been searching for suitable ways to generate 
catalytically active electrophilic ruthenium-hydride complexes and to 
explore their activity for the C-H bond activation reactions. This report 
delineates in-situ generation of the cationic ruthenium-hydride catalyst 
from the protonation reaction of tetranuclear ruthenium complex 
{[(PCy3)(CO)RuH]4(μ4-O)(μ3-OH)(μ2-OH)} (1),9 and its unusual 
activity and selectivity pattern toward the coupling reaction of 
arylketones and alkenes involving C-H bond activation.  
 
(1) 
Initially, catalytic activity of electrophilic ruthenium complexes 
was surveyed for the coupling reaction of acetophenone and 1-hexene. 
1-Hexene was chosen because it is normally not considered a suitable 
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substrate for the chelate-assisted ortho-C–H insertion reaction 
pioneered by Murai and coworkers (eq 1).10 Remarkably, the catalytic 
activity of 1 was “turned-on” upon the addition of HBF4·OEt2 (2 
equiv/Ru atom) to give a ∼1:1 mixture of the substituted indene 
product 2a and the ortho-C–H insertion product 3a (Table 1).11 Other 
selected ruthenium and rhenium catalysts were ineffective for the 
coupling reaction, giving only acid-catalyzed aldol condensation 
products. The structure of the coupling product 2a revealed an 
unusual alkene insertion regioselectivity. The product 2a, whose 
structure was completely established by 2-D NMR techniques, showed 
two methyl groups with 2-propyl group on the indenyl ring, even 
though 1-hexene was used as the substrate. While a conceptually 
similar dehydrative coupling reaction of imines and alkenes was 
reported by Takai and co-workers,12 to the best of knowledge, the 
formation of substituted indenes from the coupling reaction of ketones 
and alkenes has not been achieved before. 
Table 1. Catalyst Survey for the Coupling Reaction of Acetophenone and 1-
Hexene.a 
entry catalyst additive yieldb 2a:3a 
1 1 -- 0 -- 
2 1 HBF4·OEt2 44 43:57 
3 RuHCl(CO)(PCy3)2 -- 0 -- 
4 RuHCl(CO)(PCy3)2 HBF4·OEt2 19 43:57 
5 RuH2(CO)(PPh3)3 -- 7 0:100 
6 RuH2(CO)(PPh3)3 HBF4·OEt2 0 --c 
7 RuCl2(PPh3)3 HBF4·OEt2 5 100:0c 
8 RuCl3·3H2O HBF4·OEt2 0 --c 
9 [RuCl2(COD)]x HBF4·OEt2 0 --c 
10 Ru3(CO)12 NH4PF6 0 -- 
11d [RuH(CO)(PCy3)2(S)2]+BF4− -- 0 -- 
12 Re(CO)3(THF)2Br HBF4·OEt2 0 --c 
13 BF3·OEt2 -- 0 --c 
14 HBF4·OEt2 -- 0 --c 
aReaction conditions: acetophenone (1.0 mmol), 1-hexene (10 mmol), catalyst (5 
metal atom mol%), additive (2 equiv), C6H5Cl (1 mL), 110−120 °C, 15 h. 
bGC yields based on acetophenone. 
c10−15% of the aldol products was formed. 
dS = CH3CN. 
The scope of the coupling reaction was explored by using 
1/HBF4·OEt2 catalytic system (Table 2). Arylketone with an electron-
withdrawing group was found to marginally favor the formation of the 
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indene product 2 (entry 2), while the ketone with sterically demanding 
group tended to increase the formation of the ortho-C–H insertion 
product 3 (entry 4, 5). The coupling reaction with both ethylene and 
2-butene formed the same products 2j and 3j rapidly within 1 h (entry 
10, 11), and this observation can be rationalized by the ethylene 
dimerization and 1-butene to 2-butene isomerization prior to the 
coupling reaction. In all cases, high regioselectivity in forming the 
substituted indene product 2, and a mixture of the double bond 
isomers is formed for unsymmetric products such as 2h, 2i and 2l 
(entry 8, 9 and 13). In contrast, the coupling reaction with styrene 
predominantly gave the ortho-alkenyl product 4k (entry 12), which is 
likely resulted from the vinyl C–H bond activation. The reaction with a 
benzocyclic ketone such as α-tetralone gave the ortho-C–H insertion 
product 3o exclusively (entry 16).  
 
(2) 
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Table 2. Coupling Reaction of Arylketones and Alkenes.a 
 
The following experiments were performed to gain mechanistic 
insights on the coupling reaction. (1) The treatment acetophenone-d8 
with 1-hexene (10 equiv) led to a rapid and extensive H/D exchange 
on the ortho positions of acetophenone-d8 within 1 h at 110 °C prior to 
the product formation (eq 2, Figure S2 in the Supporting Information). 
Also, a negligible isotope effect of kH/kD = 1.13±0.05 at 110 °C was 
obtained from the coupling reaction of acetophenone vs acetophenone-
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d8 with 1-hexene. These results indicate a rapid and reversible ortho-
C–H bond activation step. (2) Carbon isotope effect was measured 
from the coupling reaction of 2-acetonaphthone and 1-hexene by 
employing Singleton's isotope measurement technique at natural 
abundance.13 The 12C/13C ratio of unreacted 2-acetonaphthone isolated 
at 71% conversion was compared with the virgin sample. The most 
pronounced carbon isotope effect was observed at the ortho-arene 
carbon atom of 2-acetonaphthone (12C/13C at C(3) = 1.020 with C(7) as 
the internal standard, average of 3 runs) (Table S1, Supporting 
Information). 
(3) A catalytically relevant ruthenium-hydride species was 
detected from the reaction mixture of 1 and HBF4·OEt2. Thus, the 
treatment of 1 (20 mg, 12 μmol) with HBF4·OEt2 (6.5 μL, 2 equiv per 
Ru) in C6D6 at 20 °C led to a clean formation of the ruthenium-hydride 
complex, whose spectroscopic features are characterized by the Ru–H 
signal at δ −10.79 (d, JPH = 25.8 Hz) by 1H NMR and a single 
phosphine peak at δ 73.8 by 31P{1H} NMR. We tentatively formulate 
the structure of the cationic Ru–H species as [(L)3(PCy3)(CO)RuH]+ on 
the basis of these spectroscopic data. Furthermore, the in-situ formed 
complex was found to be an active catalyst for the coupling reaction. 
While details of the reaction mechanism remain unclear, these 
preliminary results suggest a mechanism involving a rapid and 
reversible ortho-C–H bond activation followed by the rate-limiting 
olefin insertion step for the coupling reaction (Scheme 1). We propose 
that the cationic ortho-metalated complex 5, formed from the ortho-
C–H bond activation of an arylketone and the reductive elimination of 
an alkane, is the key species for the coupling reaction.14 The 
regioselective insertion of 2-alkene to 5 and the subsequent cyclization 
and dehydration sequence can be envisioned for the formation of 2. 
The observation of significant carbon isotope effect on the ortho-arene 
carbon of an arylketone substrate supports the notion that the C-C 
bond-forming step involving the migratory insertion of 2-alkene to the 
ortho-metalated species 5 is the rate-limiting step of the coupling 
reaction. 
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Scheme 1. Proposed Mechanism for the Formation of 2. 
Electrophilic nature of the ruthenium-hydride catalyst appears to 
be an important factor in mediating the coupling reaction, in that the 
cationic ruthenium catalyst would promote the dehydrative cyclization 
steps by facilitating strong dative bonding interaction with the ketone 
oxygen atom. Heteroatomchelated ortho-metalated late transition 
complexes have been widely considered to be the key intermediate 
species in both Murai-type of C-H/olefin insertion and oxidative C-H 
arylation reactions.15 The cationic nature of the ruthenium-hydride 
catalyst would also be proficient in mediating the isomerization of 
terminal alkenes, and in this regard, the activity of electrophilic 
ruthenium catalysts towards alkenes isomerization and other coupling 
reactions has been well-documented in the literature.16 Detailed kinetic 
and mechanistic investigations are currently underway to further 
discern the electrophilic nature of the ruthenium-hydride catalyst on 
the coupling reaction. 
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General Information.  All operations were carried out in an inert-atmosphere glove box or 
by using standard high vacuum and Schlenk techniques unless otherwise noted. Tetrahydrofuran, 
benzene, hexanes and Et2O were distilled from purple solutions of sodium and benzophenone 
immediately prior to use. The NMR solvents were dried from activated molecular sieves (4 Å).  
All organic substrates were received from commercial sources and used without further 
purification. The 1H, 2H, 13C and 31P NMR spectra were recorded on a Varian 300 or 400 MHz 
FT-NMR spectrometer. Mass spectra were recorded from a Agilent 6850 GC/MS spectrometer. 
The conversion of organic products was measured from a Hewlett-Packard HP 6890 GC 
spectrometer. Elemental analysis was performed at the Midwest Microlab, Indianapolis, IN. 
 
Representative Procedure of the Catalytic Reaction. In a glove box, complex 1 (30 mg, 
17.7 µmol) was dissolved in chlorobenzene (3 mL) in a 25 mL Schlenk tube equipped with a 
Teflon screw cap stopcock and a magnetic stirring bar. The tube was brought out of the box, and 
HBF4·OEt2 (20 µL, 0.14 mmol) was added to the reaction tube under a stream of nitrogen gas. 
The tube was brought into the glove box, and both ketone (1.0 mmol) and alkene (10 mmol) 
substrates were added to the tube. The tube was brought out of the box, and was stirred for 15 h 
in an oil bath which was preset at 110 °C. After the tube was cooled to room temperature, the 
solution was filtered through a short silica plug (hexanes/EtOAc = 2:1) in air, and the solution 
was analyzed by GC. Analytically pure organic product was isolated after a simple column 
chromatography on silica gel (hexanes/EtOAc). 
 
Detection of the Cationic Ruthenium-Hydride Complex. In a J-Young NMR tube 
equipped with a screw cap, complex 1 (20 mg, 12 µmol) was dissolved in C6D6 (0.5 mL) at room 
temperature. HBF4·OEt2 (6.5 µL, 47 µmol) was added to the NMR tube via syringe under 
nitrogen atmosphere. The color of solution was changed from dark red to pale yellow after the 
tube was shaken a few times. Selected spectroscopic data of the new ruthenium-hydride 
complex: 1H NMR (C6D6, 400.0 MHz) δ -10.79 (d, JPH = 25.8 Hz, Ru-H); 31P{1H} NMR (C6D6, 
 3 S 
161.8 MHz) δ 73.8 (PCy3); IR (C6D6) νCO = 1992 cm-1. 
 
Deuterium Isotope Effect Study. In a glove box, complex 1 (30 mg, 17.7 µmol) was 
dissolved in chlorobenzene (3 mL) in a 25 mL Schlenk tube equipped with a Teflon stopcock 
and a magnetic stirring bar. The tube was brought out of the box, and HBF4·OEt2 (20 µL, 0.14 
mmol) was added to the reaction tube under nitrogen atmosphere. The tube was again brought 
into the glove box, and acetophenone (0.120 g, 1.0 mmol) or acetophenone-d8 (0.128 g, 1.0 
mmol) and 1-hexene (0.84 g, 10 mmol) were added to the tube. After the solution was stirred at 
room temperature for 10 min, an equal amount of the solution (0.6 mL) was divided and placed 
in 6 different Schlenk tubes. The tubes were brought out of the box, and were stirred in an oil 
bath which was preset at 110 °C. Each reaction tube was taken out from the oil bath in 10 min 
intervals, and was immediately cooled in a dry ice/acetone bath. After filtering through a small 
silica gel column (hexanes/EtOAc = 2:1), the solution was analyzed by GC. The kobs was 
determined from a first-order plot of ln[2a] vs time as measured by the appearance of the product 
2a by GC (Figure S1). 
 
Deuterium Labeling Study. Complex 1 (10 mg, 5.9 µmol) was dissolved in 
chlorobenzene (0.5 mL) in a J-Young NMR tube. HBF4·OEt2 (6.5 µL, 47 µmol) was added to the 
NMR tube under nitrogen atmosphere. The tube was brought into the glove box, and 
acetophenone-d8 (43 mg, 0.34 mmol) and 1-hexene (0.28 g, 3.4 mmol) were added to the NMR 
tube. The tube was brought out of the box, and 2H NMR was initially recorded at room 
temperature. The NMR tube was immersed in an oil bath which was preset at 110 °C for 1 h. The 
tube was cooled and the 2H NMR was recorded at room temperature (Figure S2). 
 
 4 S 
Figure S1. First-Order Plots of the Reaction of Acetophenone and Acetophenone-d8 with 1-
Hexene.  
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Figure S2. 2H NMR Spectra from the Reaction of Acetophenone-d8 and 1-Hexene in 
Chlorobenzene. 
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Carbon Isotope Effect Study. In a glove box, complex 1 (150 mg, 89 µmol) was 
dissolved in chlorobenzene (10 mL) in two separate 25 mL Schlenk tubes equipped with a 
Teflon stopcock and a magnetic stirring bar. The tubes were brought out of the box, and 
HBF4·OEt2 (100 µL, 0.70 mmol) was added via syringe to each reaction tubes under nitrogen 
atmosphere. The tubes were brought into the glove box, and 2-acetonaphthone (0.60 g, 3.5 
mmol) and 1-hexene (3.0 g, 36 mmol) were added to each tubes. The tubes were brought out of 
the box, and were stirred in an oil bath which was preset at 110 °C for 10 and 14 h, respectively. 
The tubes were immediately cooled. After filtering through a small silica gel column 
(hexanes/EtOAc = 2:1) in air, the product conversion was determined by GC (71% and 78% 
conversion). Unreacted 2-acetonaphthone was recovered by a column chromatography on silica 
gel (hexanes/EtOAc) for the 13C{1H} NMR analysis. 
 
 The 13C NMR analysis of the recovered and virgin samples of 2-acetonaphthone was 
performed by following Singleton’s 13C NMR method (ref #12 in the main text). The NMR 
sample of virgin and recovered 2-acetonaphthone was prepared identically by dissolving 2-
acetonaphthone (100 mg) in CDCl3 (0.5 mL) in a 5 mm high precision NMR tube. The 13C{1H} 
NMR spectra were recorded with H-decoupling and 45 degree pulses. A 60 s delay between 
pulses was imposed to minimize T1 variations (d1 = 60 s, at = 5.0 s, np = 245098, nt = 512). The 
data are summarized in Table S1. 
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Table S1. Average 13C Integration of the Recovered and Virgin Samples of 2-
Acetonaphthone. 
 
1
2
3
4
5
6
7(ref)
8
9
10
1.011(3)
1.032(3)
0.994(4)
1.036(4)
1.040(2)
1.036(4)
1.000 
0.992(3)
1.034(4)
1.032(4)
1.005(4)
1.023(4)
1.014(5)
1.027(5)
1.038(4)
1.027(5)
1.000 
0.999(2)
1.029(4)
1.025(5)
0.994(4)
0.991(4)
1.020(5)
0.991(5)
0.998(3)
0.991(5)
1.000 
1.007(3)
0.995(4)
0.993(5)
-0.59(4)
-0.87(4)
+2.01(5)
-0.87(5)
-0.19(3)
-0.87(5)
0.00 
+0.71(3)
-0.48(4)
-0.68(5)
C # virgin   recovered (71% conv.)
recovered/virgin change (%)
1
2
3
4
5
6
7(ref)
8
9
10
1.011(3)
1.032(3)
0.994(4)
1.036(4)
1.040(2)
1.036(4)
1.000 
0.992(3)
1.034(4)
1.032(4)
1.008(4) 
1.040(5) 
1.032(6) 
1.031(4) 
1.020(5) 
1.030(4) 
1.000 
1.008(6) 
1.036(4) 
1.041(4)
0.997(4) 
1.008(5) 
1.038(6) 
0.995(4) 
0.981(5) 
0.994(4) 
1.000 
1.016(6) 
1.002(4)
1.009(4)
0.30(4) 
0.78(5)
3.82(6) 
-0.48(4) 
-1.92(5)
-0.58(4) 
0.00 
1.61(6) 
0.19(4) 
0.87(4)
C # virgin   recovered (78% conv.)
recovered/virgin change (%)
 
 
O
1
2
3
4
105
6
7
8
9
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Characterization Data of Organic Products 
For 2a: 1H NMR (400 MHz, CDCl3) δ 7.50-7.15 (m, 5H, Ar), 3.36 (q, J = 7.8 Hz, CHCH3), 
2.52 (m, =CCH2), 2.20 (s, =CCH3), 1.50 (m, CH2CH3), 1.34 (d, J = 7.8 Hz, CHCH3), 1.01 (t, J = 
7.5 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 148.6 (=CCH2), 147.8, 146.3 (Ar), 131.5 
(=CCH3), 126.4, 124.0 and 118.3 (Ar), 44.8 (CHCH3), 28.6 (=CCH2), 23.3 (CH2CH3), 16.6 
(CHCH3), 14.4 (CH2CH3), 10.5 (=CCH3); GC-MS m/z = 186 (M+). 
 
For 2b: 1H NMR (400 MHz, CDCl3) δ 7.36 (s, 1H, Ar), 7.27 and 7.15 (d, J = 8.8 Hz, 2H, Ar), 
3.31 (m, CHCH3), 2.50 (m, =CCH2), 2.06 (s, =CCH3), 1.50 (m, CH2CH3), 1.29 (d, J = 7.5 Hz, 
CHCH3), 1.01 (t, J = 7.5 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 149.8 (=CCH2), 
148.2, 146.7 and 144.8 (Ar), 131.0 (=CCH3), 126.5, 123.2 and 118.6 (Ar), 44.5 (CHCH3), 28.7 
(=CCH2), 23.1 (CH2CH3), 15.9 (CHCH3), 14.3 (CH2CH3), 10.4 (=CCH3); GC-MS m/z = 220 
(M+). 
 
For 2c: 1H NMR (400 MHz, CDCl3) δ 7.28 and 7.19 (d, J = 8.2 Hz, 2H, Ar), 6.88 (s, 1H, Ar), 
3.85 (s, OCH3), 3.39 (q, J = 7.8 Hz, CHCH3), 2.50 (m, =CCH2), 2.12 (s, =CCH3), 1.42 (m, 
CH2CH3), 1.26 (d, J = 7.5 Hz, CHCH3), 0.97 (t, J = 7.5 Hz, CH2CH3); 13C{1H} NMR (100 MHz, 
CDCl3) δ 159.0, 142.5, 138.6, 122.7, 110.1 and 105.3 (Ar), 150.8 (=CCH2), 132.3 (=CCH3), 55.7 
(OCH3), 43.1 (CHCH3), 30.3 (=CCH2), 23.2 (CH2CH3), 16.8 (CHCH3), 14.3 (CH2CH3), 10.5 
(=CCH3); GC-MS m/z = 216 (M+). 
 
For 2d: 1H NMR (400 MHz, CDCl3) δ 7.50-7.20 (m, 5H, Ar), 3.42 (m, CHCH2), 2.60 (m, 
=CCH2), 2.10 (s, =CCH3), 1.70 (m, CHCH2), 1.40 (m, CH2CH3), 1.01 (t, J = 7.5 Hz, 
CH2CH2CH3), 0.62 (t, J = 7.5 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 148.7 
(=CCH2), 145.6 and 143.8 (Ar), 132.9 (=CCH3), 126.3, 122.6, 119.1 and 118.2 (Ar), 50.5 
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(ArCH), 32.0, 28.8 and 25.0 (CH2), 23.3 (=CCH3), 14.4 (CH2CH2CH3), 8.9 (CHCH2CH3); GC-
MS m/z = 200 (M+). 
 
For 2e: 1H NMR (400 MHz, CDCl3) δ 7.46-7.10 (m, 5H, Ar), 3.38 (m, CHCH(CH3)2), 2.35 
(m, CH(CH3)2), 2.05 (s, =CCH3), 1.70 (m, CHCH2), 1.40 (m, CH2CH3), 0.98 (t, J = 7.5 Hz, 
CH2CH2CH3), 0.63 (t, J = 6.8 Hz, 6H, CH(CH3)2); 13C{1H} NMR (100 MHz, CDCl3) δ 147.9 
(=CCH2), 144.6 and 130.8 (Ar), 130.5 (=CCH3), 126.3, 124.6, 123.1 and 119.0 (Ar), 55.6 
(ArCH), 30.4 and 17.9 (CH2), 29.1 (CH(CH3)2), 22.9 (=CCH3), 21.9 (CH(CH3)2), 14.3 
(CH2CH2CH3), 8.9 (CHCH2CH3); GC-MS m/z = 214 (M+). 
 
For 2f: 1H NMR (400 MHz, CDCl3) δ 7.60-7.18 (m, 9H, Ar), 3.70 (m, CHCH3), 2.78 (m, 
=CCH2), 1.82 (m, CH2CH3), 1.58 (d, J = 7.8 Hz, CHCH3), 1.02 (t, J = 7.5 Hz, CH2CH2CH3); 
13C{1H} NMR (100 MHz, CDCl3) δ 146.8 (=CCH2), 129.4 (=CPh), 140.7, 128.7, 128.5, 128.3, 
127.7, 126.7, 124.6, 123.4, 118.4 (Ar), 57.2 (ArCH), 29.0 and 23.1 (CH2), 14.4 (CH2CH3), 10.6 
(CHCH3); GC-MS m/z = 248 (M+). 
 
For 2g: 1H NMR (400 MHz, CDCl3) δ 8.11 (m, 2H, Ar), 7.97 and 7.87 (s, 2H, Ar), 7.71 (m, 
2H, Ar), 3.73 (q, J = 7.5 Hz, CHCH3), 2.80 and 2.62 (m, =CCH2), 2.42 (s, =CCH3), 1.79 (m, 
CH2CH3), 1.61 (d, J = 7.5 Hz, CHCH3), 1.28 (t, J = 7.5 Hz, CH2CH3); 13C{1H} NMR (100 MHz, 
CDCl3) δ 149.4 (=CCH2), 147.0, 145.5, 133.6 and 132.0 (Ar), 131.6 (=CCH3), 128.0, 127.9, 
125.1, 124.5, 120.7 and 115.5 (Ar), 44.1 (CHCH3), 28.8 (=CCH2), 22.7 (CH2CH3), 16.8 
(CHCH3), 14.4 (CH2CH3), 10.5 (=CCH3); GC-MS m/z = 236 (M+); Anal. Calcd for C18H20: C, 
91.47; H, 8.53. Found: C, 91.64; H, 8.46.  
 
For 2h: 1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 10.9, 8.4 Hz, 1H, Ar), 7.72 (t, J = 10.7 
Hz, 2H, Ar), 7.59 (d, J = 11.3 Hz, 1H, Ar), 7.33 (dt, J = 8.1, 1.4 Hz, 1H, Ar), 3.53 (q, J = 7.4 Hz, 
CHCH3), 2.61 (s, ArCH3), 2.60 and 2.42 (m, 2H, =CCH2), 2.21 (s, =CCH3), 1.72 and 1.60 (m, 
 10 S 
2H, CH2CH3), 1.42 (d, J = 7.4 Hz, CHCH3), 1.07 (t, J = 7.4 Hz, CH2CH3); 13C{1H} NMR (100 
MHz, CDCl3) δ 149.4 (=CCH2), 148.9, 147.2, 146.2, 145.6, 144.8, 134.5, 134.0, 133.8 and 132.2 
(Ar), 131.7 (=CCH3), 131.6, 130.2, 127.8, 127.3, 127.1, 126.7, 120.5, 120.2, 115.3 and 115.0 
(Ar), 44.2 and 44.1 (CHCH3), 28.9 (=CCH2), 22.7 (CH2CH3), 21.9 (ArCH3), 16.9 (CHCH3), 14.4 
(CH2CH3), 10.5 (=CCH3); GC-MS m/z = 250 (M+); Anal. Calcd for C19H22: C, 91.14; H, 8.86. 
Found: C, 91.28; H, 8.91. 
 
For 2i: 1H NMR (400 MHz, CDCl3) δ 7.77 (m, 1H, Ar), 7.70 and 7.56 (s, 2H, Ar), 7.24 (d, J = 
12.8 Hz, 1H, Ar), 7.15 (m, 1H, Ar), 3.97 (s, OCH3), 3.50 (m, CHCH3), 2.58 and 2.40 (m, 
=CCH2), 2.18 (s, =CCH3), 1.70 and 1.56 (m, CH2CH3), 1.38 (m, CHCH3), 1.05 (m, CH2CH3); 
13C{1H} NMR (100 MHz, CDCl3) δ 157.3 and 156.8 (Ar), 149.8 (=CCH2), 148.1, 147.8, 146.1, 
144.9, 143.7, 134.6 and 132.9 (Ar), 131.6 (=CCH3), 129.4, 128.8, 127.3, 120.5, 119.9, 117.4, 
116.8, 115.4, 114.7, 106.6, 106.5 (Ar), 55.4 (OCH3), 44.1, 44.0 (CHCH3), 28.9 and 28.8 
(=CCH2), 22.8 (CH2CH3), 16.9 (CHCH3), 14.4 (CH2CH3), 10.5 (=CCH3); GC-MS m/z = 266 
(M+); Anal. Calcd for C19H22O: C, 85.67; H, 8.32. Found: C, 85.58; H, 8.39. 
 
For 2j: 1H NMR (400 MHz, CDCl3) δ 7.85 (m, 2H, Ar), 7.73 and 7.55 (s, 2H, Ar), 7.42 (m, 
2H, Ar), 3.38 (q, J = 7.5 Hz, CHCH3), 2.13 and 2.05 (s, =CCH3), 1.37 (d, J = 7.5 Hz, CHCH3); 
13C{1H} NMR (100 MHz, CDCl3) δ 147.0 and 131.3 (=CCH3), 145.6, 145.3, 133.5, 131.9, 
128.0, 127.9, 125.1, 124.5, 120.6 and 115.3 (Ar), 46.4 (CHCH3), 16.8 (CHCH3), 12.6 and 10.5 
(=CCH3); GC-MS m/z = 208 (M+). 
 
For 2l: 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.9 Hz, 1H, Ar), 7.68 and 7.51 (s, 2H, Ar), 
7.22 (d, J = 2.2 Hz, 1H, Ar), 7.10 (dd, J = 8.9, 2.6 Hz, 1H, Ar), 3.95 (s, OCH3), 2.54, 1.82 and 
1.50 (m, CH2), 1.00 and 0.60 (t, J = 7.3 Hz, CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 157.2 
(Ar), 147.7 (=CCH2), 142.8, 134.5, 132.9 and 129.4 (Ar), 127.1 (=CCH3), 120.7, 116.8, 114.5 
and 106.5 (Ar), 55.4 (OCH3), 49.5 (CHCH2), 29.0, 23.4 and 22.8 (CH2), 14.4, 10.5 and 8.9 
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(CH3); GC-MS m/z = 280 (M+); Anal. Calcd for C20H24O: C, 85.67; H, 8.63. Found: C, 85.74; H, 
8.68.  
 
For 2m: 1H NMR (400 MHz, CDCl3) δ 8.42 and 8.38 (s, 2H, Ar), 8.00 (d, J = 9.3 Hz, 2H, 
Ar), 7.85 and 7.69 (s, 1H, Ar), 7.45 (m, 2H, Ar), 3.58 (q, J = 7.4 Hz, CHCH3), 2.56 and 2.41 (m, 
=CCH2), 2.17 (s, =CCH3), 1.70 and 1.56 (m, CH2CH3), 1.40 (d, J = 7.4 Hz, CHCH3), 1.02 (t, J = 
7.4 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 150.3 (=CCH2), 146.9, 145.8, 132.3, 
131.9, 131.6 and 131.2 (Ar), 131.1 (=CCH3), 128.2, 128.1, 126.0, 125.7, 125.0, 124.7, 120.5 and 
114.8 (Ar), 43.9 (CHCH3), 29.0 (=CCH2), 22.5 (CH2CH3), 17.2 (CHCH3), 14.5 (CH2CH3), 10.5 
(=CCH3); GC-MS m/z = 286 (M+). 
 
For 3a: 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 7.8 Hz, 1H, Ar), 7.36 (dt, J = 7.5, 1.3 Hz, 
1H, Ar), 7.24 (d, J = 7.4 Hz, 2H, Ar), 2.84 (pseudo t, J = 7.9 Hz, ArCH2), 2.56 (s, COCH3), 1.55 
(m, ArCH2CH2), 1.4-1.2 (m, CH2), 0.88 (t, J = 6.7 Hz, CH2CH3); 13C{1H} NMR (100 MHz, 
CDCl3) δ 202.2 (C=O), 142.9, 138.0, 131.3, 131.1, 129.0 and 125.6 (Ar), 34.0, 31.9, 31.7, 29.4 
and 22.7 (CH2), 29.9 (COCH3), 14.1 (CH2CH3); GC-MS m/z = 204 (M+). 
 
For 3b: 1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.2 Hz, 1H, Ar), 7.21 (m, 2H, Ar), 2.80 
(pseudo t, J = 7.9 Hz, 2H, ArCH2), 2.53 (s, 3H, COCH3), 1.51 (m, ArCH2CH2), 1.4-1.2 (m, 
CH2), 0.87 (t, J = 6.8 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 200.9 (C=O), 145.5, 
137.4, 136.2, 131.2, 130.7 and 125.9 (Ar), 34.0, 31.8, 31.7, 29.5 and 22.8 (CH2), 30.0 (COCH3), 
14.2 (CH2CH3); GC-MS m/z = 238 (M+). 
 
For 3c: 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 9.1 Hz, 1H, Ar), 6.73 (m, 2H, Ar), 3.84 (s, 
OCH3), 2.89 (pseudo t, J = 7.9 Hz, ArCH2), 2.53 (s, COCH3), 1.55 (m, ArCH2CH2), 1.4-1.2 (m, 
6H, CH2), 0.88 (t, J = 6.7 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 200.0 (C=O), 
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162.0, 147.1, 132.7, 130.1, 116.9 and 110.6 (Ar), 55.5 (OCH3), 35.0, 31.9, 31.8, 29.7 and 22.9 
(CH2), 29.7 (COCH3), 14.3 (CH2CH3); GC-MS m/z = 234 (M+). 
 
For 3d: 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 7.7 Hz, 1H, Ar), 7.34 (t, J = 7.7 Hz, 1H, 
Ar), 7.23 (d, J = 7.1 Hz, 1H, Ar), 7.19 (d, J = 7.1 Hz, 1H, Ar), 2.88 (q, J = 7.3 Hz, COCH2), 2.78 
(pseudo t, J = 7.9 Hz, 2H, ArCH2), 1.55 (m, ArCH2CH2), 1.4-1.2 (m, 6H, CH2), 1.20 (t, J = 7.3 
Hz, COCH2CH3), 0.88 (t, J = 6.7 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 205.6 
(C=O), 142.3, 138.6, 130.9, 130.7, 127.9 and 125.5 (Ar), 35.2 (COCH2), 33.9, 31.9, 31.7, 29.4 
and 22.6 (CH2), 14.1 (CH2CH3), 8.4 (COCH2CH3); GC-MS m/z = 218 (M+). 
 
For 3e: 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 7.7 Hz, 1H, Ar), 7.33 (t, J = 7.3 Hz, 1H, 
Ar), 7.24 (d, J = 7.7 Hz, 1H, Ar), 7.20 (d, J = 7.3 Hz, 1H, Ar), 3.31 (heptet, J = 6.9 Hz, 
CH(CH3)2), 2.71 (pseudo t, J = 7.9 Hz, ArCH2), 1.55 (m, ArCH2CH2), 1.4-1.2 (m, 6H, CH2), 
1.15 (d, J = 6.9 Hz, 6H, CH(CH3)2), 0.87 (t, J = 6.7 Hz, CH2CH3); 13C{1H} NMR (100 MHz, 
CDCl3) δ 209.5 (C=O), 142.2, 138.7, 130.7, 130.4, 127.3 and 125.4 (Ar), 39.1 (COCH), 33.7, 
32.0, 31.7, 29.4 and 22.6 (CH2), 18.6 (CH(CH3)2), 14.1 (CH2CH3); GC-MS m/z = 232 (M+). 
 
For 3f: 1H NMR (400 MHz, CDCl3) δ 7.82 (m, 2H, Ar), 7.60-7.20 (m, 7H, Ar), 2.67 (pseudo 
t, J = 7.9 Hz, 2H, ArCH2), 1.55-1.15 (m, 8H, CH2), 0.83 (t, J = 6.8 Hz, CH2CH3); 13C{1H} NMR 
(100 MHz, CDCl3) δ 198.8 (C=O), 141.9, 138.7, 138.0, 133.2, 130.2, 128.5 and 125.2 (Ar), 33.4, 
31.8, 31.6, 29.2 and 22.6 (CH2), 14.1 (CH2CH3); GC-MS m/z = 266 (M+); Anal. Calcd for 
C19H22O: C, 85.67; H, 8.32. Found: C, 86.04; H, 8.69.  
 
For 3g: 1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1H, Ar), 7.84 (d, J = 8.1 Hz, 1H, Ar), 7.76 (d, 
J = 8.1 Hz, 1H, Ar), 7.67 (s, 1H, Ar), 7.53 (t, J = 6.9 Hz, 1H, Ar), 7.46 (t, J = 6.9 Hz, 1H, Ar), 
3.05 (pseudo t, J = 7.8 Hz, ArCH2), 2.70 (s, 3H, COCH3), 1.65 (m, ArCH2CH2), 1.5-1.3 (m, 6H, 
CH2), 0.94 (t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 201.9 (C=O), 139.3, 
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136.7, 134.7, 131.0, 130.3, 129.3, 128.5, 128.1, 127.2 and 126.0 (Ar), 34.3, 31.9, 31.8, 29.5 and 
22.8 (CH2), 29.9 (COCH3), 14.2 (CH2CH3); GC-MS m/z = 254 (M+); Anal. Calcd for C18H22O: 
C, 84.99; H, 8.72. Found: C, 85.49; H, 8.74.  
 
For 3h: 1H NMR (400 MHz, CDCl3) δ 8.14 (s, 1H, Ar), 7.74 (d, J = 8.4 Hz, 1H, Ar), 7.57 and 
7.54 (s, 2H, Ar), 7.30 (dd, J = 8.3, 1.6 Hz, 1H, Ar), 3.05 (pseudo t, J = 7.7 Hz, ArCH2), 2.70 (s, 
COCH3), 2.52 (s, ArCH3), 1.65 (m, ArCH2CH2), 1.5-1.3 (m, 6H, CH2), 0.94 (t, J = 7.1 Hz, 
CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 201.7 (C=O), 139.6, 138.2, 135.7, 135.1, 130.4, 
129.2, 128.7, 128.4, 128.3 and 126.2 (Ar), 34.4, 31.9, 31.8, 29.6 and 22.8 (CH2), 29.8 (COCH3), 
22.0 (ArCH3), 14.3 (CH2CH3); GC-MS m/z = 268 (M+); Anal. Calcd for C19H24O: C, 85.03; H, 
9.01. Found: C, 85.13; H, 9.11.  
 
For 3i: 1H NMR (400 MHz, CDCl3) δ 8.11 (s, 1H, Ar), 7.71 (d, J = 9.0 Hz, 1H, Ar), 7.53 (s, 
1H, Ar), 7.11 (dd, J = 9.0, 2.5 Hz, 1H, Ar), 7.04 (d, J = 2.5 Hz, 1H, Ar), 3.90 (s, 3H, OCH3), 
3.03 (pseudo t, J = 7.7 Hz, 2H, ArCH2), 2.67 (s, COCH3), 1.60 (m, ArCH2CH2), 1.5-1.3 (m, 6H, 
CH2), 0.91 (t, J = 6.9 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 201.2 (C=O), 159.5, 
140.4, 136.3, 133.9, 130.8, 130.1, 128.2, 126.3, 118.9 and 104.9 (Ar), 55.3 (OCH3), 34.5, 31.8 
and 22.8 (CH2), 29.5(COCH3), 14.2 (CH2CH3); GC-MS m/z = 284 (M+); Anal. Calcd for 
C19H24O2: C, 80.24; H, 8.51. Found: C, 80.64; H, 8.66.  
 
For 3j: 1H NMR (400 MHz, CDCl3) δ 8.17 (s, 1H, Ar), 7.86 and 7.78 (d, J = 8.1 Hz, 2H, Ar), 
7.67 (s, 1H, Ar), 7.54 and 7.48 (t, J = 6.9 Hz, 2H, Ar), 3.05 (pseudo t, J = 7.8 Hz, ArCH2), 2.71 
(s, COCH3), 1.64 and 1.45 (m, 4H, ArCH2CH2), 0.98 (t, J = 7.3 Hz, CH2CH3); 13C{1H} NMR 
(100 MHz, CDCl3) δ 202.1 (C=O), 139.4, 136.8, 134.8, 131.1, 130.4, 129.4, 128.6, 128.2, 127.2 
and 126.1 (Ar), 34.1, 34.0 and 22.9 (CH2), 30.0 (COCH3), 14.2 (CH2CH3); GC-MS m/z = 226 
(M+). 
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For 3l: 1H NMR (400 MHz, CDCl3) δ 8.04 (s, 1H, Ar), 7.71 (d, J = 8.9 Hz, 1H, Ar), 7.55 (s, 
1H, Ar), 7.11 (dd, J = 8.9, 2.5 Hz, 1H, Ar), 7.05 (d, J = 2.5 Hz, 1H, Ar), 3.03 (q, J = 7.3 Hz, 
COCH2), 2.99 (pseudo t, J = 7.8 Hz, ArCH2), 1.60, 1.40 and 1.30 (m, 8H, CH2), 1.25 (t, J = 7.3 
Hz, COCH2CH3), 0.91 (t, J = 7.0 Hz, 3H, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 204.9 
(C=O), 159.4, 140.2, 136.2, 134.7, 130.1, 129.4, 128.2, 126.4, 119.0 and 105.1 (Ar), 55.4 
(OCH3), 34.9 (COCH2), 34.4, 32.0, 31.9, 29.6 and 22.8 (CH2), 14.2 and 8.8 (CH3); GC-MS m/z = 
298 (M+); Anal. Calcd for C20H26O2: C, 80.50; H, 8.78. Found: C, 81.13; H, 9.00.  
 
For 3m: 1H NMR (400 MHz, CDCl3) δ 8.35 and 8.27 (s, 2H, Ar), 8.23 (s, 1H, Ar), 7.95 (m, 
2H, Ar), 7.71 (s, 1H, Ar), 7.48 (m, 2H, Ar), 3.07 (pseudo t, J = 7.8 Hz, ArCH2), 2.72 (s, 
COCH3), 1.68 (m, ArCH2CH2), 1.5-1.3 (m, 6H, CH2), 0.95 (t, J = 7.0 Hz, CH2CH3); 13C{1H} 
NMR (100 MHz, CDCl3) δ 201.7 (C=O), 138.3, 136.6, 133.2, 132.2, 131.7, 131.5, 129.3, 128.8, 
128.5, 128.2, 127.7, 126.4, 125.5 and 125.3 (Ar), 34.5, 31.9, 31.7, 29.6 and 22.8 (CH2), 29.7 
(COCH3), 14.3 (CH2CH3); GC-MS m/z = 304 (M+); Anal. Calcd for C22H24O: C, 86.80; H, 7.95. 
Found: C, 86.73; H, 8.06.  
 
For 3n: 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 9.4 Hz, 1H, Ar), 6.67 (m, 2H, Ar), 3.83 
(pseudo t, J = 5.0 Hz, 4H, OCH2), 3.26 (pseudo t, J = 5.0 Hz, 4H, NCH2), 2.90 (pseudo t, J = 7.6 
Hz, ArCH2), 2.51 (s, COCH3), 1.55-1.25 (m, 8H, CH2), 0.87 (t, J = 6.6 Hz, CH2CH3); 13C{1H} 
NMR (100 MHz, CDCl3) δ 199.0 (C=O), 153.1, 146.7, 132.8, 127.6, 116.7 and 110.8 (Ar), 66.7 
(OCH2), 47.7 (NCH2), 35.5, 31.9, 31.8, 29.7 and 22.8 (CH2), 29.2 (COCH3), 14.2 (CH3); GC-MS 
m/z = 289 (M+); Anal. Calcd for C18H27NO2: C, 74.70; H, 9.40. Found: C, 74.90; H, 9.47.  
 
For 3o: 1H NMR (400 MHz, CDCl3) δ 7.31 (t, J = 7.6 Hz, 1H, Ar), 7.09 and 7.08 (d, J = 7.6 
Hz, 2H, Ar), 3.02 (pseudo t, J = 7.7 Hz, 2H, ArCH2), 2.94 (t, J = 6.1 Hz, COCH2), 2.64 (t, J = 
6.6 Hz, =CCH2), 2.07 (quintet, J = 6.4 Hz, 2H, COCH2CH2), 1.55-1.25 (m, 8H, CH2), 0.89 (t, J = 
7.0 Hz, CH2CH3); 13C{1H} NMR (100 MHz, CDCl3) δ 200.1 (C=O), 146.5, 146.0, 132.3, 131.0, 
 15 S 
130.0 and 126.9 (Ar), 41.3, 35.6 and 22.9 (cyclic CH2), 31.9, 31.7, 31.3, 29.8 and 23.1 (CH2), 
14.3 (CH3); GC-MS m/z = 230 (M+); Anal. Calcd for C16H22O: C, 83.43; H, 9.63. Found: C, 
83.40; H, 9.72.  
 
O
Cl
4k
 
For 4k: 1H NMR (400 MHz, CDCl3) δ 7.68 (m, 1H, Ar), 7.65 (d, J = 16.5 Hz, CH=CH), 7.53-
7.30 (m, 4H, Ar), 6.69 (d, J = 16.5 Hz, CH=CH), 2.60 (s, COCH3); 13C{1H} NMR (100 MHz, 
CDCl3) δ 201.0 (C=O), 139.7, 138.1, 137.0, 135.5, 133.0, 128.9, 127.5, 127.3, 127.2 and 126.4 
(Ar), 130.9 and 128.5 (CH), 30.0 (COCH3); GC-MS m/z = 256 (M+). 
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